Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list Medical Dialogues Bureau29 Nov 2019 9:15 AM ISTSeventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 12:44 PM ISTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year Medical Dialogues Bureau18 Aug 2019 9:36 AM ISTA four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
Abbvie finalizes deal to buy Botox maker Allergan for $63 billion Medical Dialogues Bureau26 Jun 2019 10:00 AM ISTA note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
Abbvie to record $4 billion impairment charges on Stemcentrx assets Medical Dialogues Bureau6 Jan 2019 9:00 AM ISTThe drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
